IL13Rα2 CAR-T for Patients With r/r Glioma
Clinical trial NCT06355908 · SUSPENDED
Trial details
- NCT number
- NCT06355908
- Sponsor
- Yang Zhang
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2026-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.